Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC
Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC
复制标题
DOI:
10.1002/lsm.10113
复制
发表时间:
2003-01-01
影响因子:
2.4
通讯作者:
Ris, HB
中科院分区:
文献类型:
--
作者:
Krueger, T;Altermatt, HJ;Ris, HB
Background and Objectives: Experimental assessment of photodynamic therapy (PDT) for malignant pleural mesothelioma using a polyethylene glycol conjugate of meta-tetrahydroxyphenylchlorin (PEG-mTHPC).Study Design/Materials and Methods: (a) PDT was tested on H-meso-1 xenografts (652 nm laser light; fluence 10 j/cm(2); 0.93, 9.3, or 27.8 mg/kg of PEG-mTHPC; drug-light intervals 3-8 days). (b) Intraoperative PDT with similar treatment conditions was performed in the chest cavity of minipigs (n = 18) following extrapleural pneumonectomy (EPP) using an optical integrating balloon device combined with in situ light dosimetry.Results: (a) PDT using PEG-mTHPC resulted in larger extent of tumor necrosis than in untreated tumors (P less than or equal to 0.01) without causing damage to normal tissue. (b) Intraoperative PDT following EPP was well tolerated in 17 of 18 animals. Mean fluence and fluence rates measured at four sites of the chest cavity ranged from 10.2 +/- 0.2 to 13.2 +/- 2.3 J/cm(2) and 5.5 +/- 1.2 to 7.9 +/- 1.7 mW/cm(2) (mean +/- SD). Histology 3 months after light delivery revealed no PDT related tissue injury in all but one animal.Conclusions: PEG-mTHPC mediated PDT showed selective destruction of mesothelioma xenografts without causing damage to intrathoracic organs in pigs at similar treatment conditions. The light delivery system afforded regular light distribution to different parts of the chest cavity. (C) 2003 Wiley-Liss, Inc.